EW
Edwards Lifesciences CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$47.44B
P/E Ratio
45.97
EPS
$1.79
Beta
0.94
52W High
$87.89
52W Low
$72.30
50-Day MA
$81.76
200-Day MA
$80.95
Dividend Yield
—
Profit Margin
17.40%
Forward P/E
27.93
PEG Ratio
2.13
About Edwards Lifesciences Corp
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Fundamentals
| Revenue (TTM) | $6.30B |
| Gross Profit (TTM) | $4.91B |
| EBITDA | $1.90B |
| Operating Margin | 31.20% |
| Return on Equity | 10.30% |
| Return on Assets | 7.65% |
| Revenue/Share (TTM) | $10.81 |
| Book Value | $17.80 |
| Price-to-Book | 4.66 |
| Price-to-Sales (TTM) | 7.53 |
| EV/Revenue | 7.35 |
| EV/EBITDA | 30.76 |
| Quarterly Earnings Growth (YoY) | 8.20% |
| Quarterly Revenue Growth (YoY) | 16.70% |
| Shares Outstanding | $576.54M |
| Float | $579.02M |
| % Insiders | 0.17% |
| % Institutions | 92.95% |
Historical Volatility
HV 10-Day
38.99%
HV 20-Day
30.93%
HV 30-Day
28.03%
HV 60-Day
30.22%
HV Rank
82.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($96.96 target)
5
Strong Buy16
Buy10
HoldData last updated: 4/29/2026